Avicanna Inc's stock is making waves on the TSX, surging 5% in a single trading day.
Avicanna Inc (AVCN.TO) saw its stock price rise by 5% today, reaching CA$0.10. This increase comes as interest in the medical cannabis sector grows, with the company expanding its offerings and integrating into the Canadian healthcare landscape.
Advertisement
Avicanna Inc
AVCN.TO
AVCN.TO
Avicanna Inc
WealthAwesomeMarket cap
$13.44M
52W high
$0.30
52W low
$0.10
1W change
-4.76%
Beta
0.34
Analyst Price Targets
Based on analyst covering AVCN · as of Sep 17, 2026
Wall Street analysts forecast AVCN stock price to rise 600.0% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$0.70
+600.0% Upside
Current Price
C$0.10
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on AVCN's historical volatility
30-Day Vol
90.7%
Annualized
90-Day Vol
78.0%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$0.08
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.09 | C$0.07 – C$0.13 |
| 60 trading days | C$0.09 | C$0.06 – C$0.14 |
| 90 trading days | C$0.08 | C$0.05 – C$0.14 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Keep an eye on Avicanna's strategic initiatives and market developments, as they could influence its stock performance.
Avicanna Inc's stock jumps 5% today.
The stock's rise brings its market capitalization to about CA$13.4 million, showcasing its potential for growth in a competitive industry.
Bull case
The recent surge in Avicanna's stock reflects increasing investor confidence. This boost may be driven by the company's innovative healthcare programs and the positive sentiment surrounding cannabis-related investments.
Bear case
Despite today's gains, Avicanna faces challenges, including a negative profit margin and ongoing market volatility in the cannabis sector, which could affect its future performance.
Market Reaction
Advertisement
Avicanna Inc's stock is rising today, indicating growing interest among investors in the company's potential. With a market cap of CA$13.4 million, the increase in stock price signals optimism about its future prospects, especially in the evolving medical cannabis landscape.
Strategic Developments
The company's recent initiatives, like the launch of the MyMedi.ca Integrated Healthcare Program, likely contribute to this positive sentiment. This program aims to integrate medical cannabis into Canadian healthcare systems, positioning Avicanna as a key player in the sector.
Looking Ahead
While today's gains are encouraging, investors should remain cautious. Avicanna's negative profit margin and the broader challenges facing the cannabis industry could impact its long-term performance. Staying informed about market developments will be crucial for making smart investment decisions.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
